Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08NKL
|
||||
| Former ID |
DNC013753
|
||||
| Drug Name |
Isorhamnetin 3,7-disulfate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [534149] | ||
| Formula |
C16H10K2O13S2
|
||||
| Canonical SMILES |
COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)OS(=O)(=O)[O-<br />])O)OS(=O)(=O)[O-])O.[K+].[K+]
|
||||
| InChI |
1S/C16H12O13S2.2K/c1-26-11-4-7(2-3-9(11)17)15-16(29-31(23,24)25)14(19)13-10(18)5-8(6-12(13)27-15)28-30(20,21)22;;/h2-6,17-18H,1H3,(H,20,21,22)(H,23,24,25);;/q;2*+1/p-2
|
||||
| InChIKey |
JILXHFDBMPFPLQ-UHFFFAOYSA-L
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Aldose reductase | Target Info | Inhibitor | [534149] | |
| NetPath Pathway | IL1 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| References | |||||